Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
791
-
Total 13F shares, excl. options
-
86.2M
-
Shares change
-
+636K
-
Total reported value, excl. options
-
$21B
-
Value change
-
+$210M
-
Put/Call ratio
-
2.63
-
Number of buys
-
417
-
Number of sells
-
-326
-
Price
-
$244.12
Significant Holders of RESMED INC - COM (RMD) as of Q3 2024
912 filings reported holding RMD - RESMED INC - COM as of Q3 2024.
RESMED INC - COM (RMD) has 791 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.2M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (18M shares), BlackRock, Inc. (11.9M shares), STATE STREET CORP (6.26M shares), Bank of New York Mellon Corp (5.71M shares), MORGAN STANLEY (4.48M shares), GEODE CAPITAL MANAGEMENT, LLC (3.86M shares), Invesco Ltd. (1.76M shares), NORTHERN TRUST CORP (1.41M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (924K shares), and Legal & General Group Plc (915K shares).
This table shows the top 791 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.